OTL-489(OTL-489) - 在研适应症：肺癌_专利_临床

概要

基本信息

药物类型

小分子化药

别名

near infrared dye(On Target Laboratories)、OTL-489

靶点-

作用机制-

治疗领域

肿瘤呼吸系统疾病

在研适应症

肺癌

非在研适应症-

原研机构

On Target Laboratories LLC

在研机构

On Target Laboratories LLC

非在研机构-

最高研发阶段药物发现

首次获批日期-

最高研发阶段(中国)-

特殊审评-

关联

2

项与 OTL-489 相关的临床试验

NCT04935866 / RecruitingN/AIIT

Optimal Brain Oxygenation in Neurologic Intensive Care Unit : The NeurO2 Study

The NeurO2 study is a multicenter observational study looking at NIRS monitoring in neurocrocritically ill patients during the acute phase of care following an acute brain injury. The study is nested within the HEMOTION Trial and the SAHaRA Trial

开始日期2021-05-07

申办/合作机构

Canadian Critical Care Trials Group

[+1]

NCT03367975 / Unknown statusN/AIIT

NIRS Monitoring During Intracranial Interventions (NIRS_ICG)

Near infrared spectroscopy is a valuable tool to monitor cerebral oxygenation during intracranial interventions. However, it yields artificial results when the dye indocyanine green (ICG) is applied, which is routinely done for intraoperative angiography.
The investigators examine, to what extent and which duration NIRS is disturbed following ICG application.

开始日期2014-03-01

申办/合作机构